180 Life Sciences P/E
Mi az 180 Life Sciences P/E?
A P/E az 180 Life Sciences Corp. - 0.53
Mi a P/E meghatározása?
Ár / nyereség arány a vállalat részvényárfolyamának aránya a társaság egy részvényre jutó nyereségével, amelyet tizenkét hónap alatt számítottak ki.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E a Health Care szektor a NASDAQ-on cégekben a 180 Life Sciences -hoz képest
Mit csinál 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
p/e -hoz hasonló cégek 180 Life Sciences
- QuantumScape nak P/E 0.52 van
- Eastnine AB (publ) nak P/E 0.52 van
- CNFinance Ltd nak P/E 0.52 van
- China Metal Resources Utilization nak P/E 0.52 van
- Datametrex AI nak P/E 0.52 van
- Warehouses De Pauw NV nak P/E 0.53 van
- 180 Life Sciences nak P/E 0.53 van
- Salzgitter AG nak P/E 0.53 van
- Euromedis e nak P/E 0.53 van
- Star Equity nak P/E 0.54 van
- AMTD IDEA nak P/E 0.55 van
- Prairie Provident Resources nak P/E 0.55 van
- Brighthouse nak P/E 0.55 van